B
Beijing Winsunny Pharmaceutical Co Ltd
SSE:601089
Beijing Winsunny Pharmaceutical Co Ltd
SSE:601089
Price:
21.82
CNY
1.54%
Market Closed
Market Cap:
¥4.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
Beijing Winsunny Pharmaceutical Co Ltd
SSE:601089
|
CN |
|
Zhejiang Dahua Technology Co Ltd
SZSE:002236
|
CN |
|
Cholamandalam Financial Holdings Ltd
NSE:CHOLAHLDNG
|
IN |
|
Falck Renewables SpA
F:AA4
|
IT |
|
Array Technologies Inc
NASDAQ:ARRY
|
US |
|
Goldwin Inc
TSE:8111
|
JP |
|
Q
|
Quinenco SA
SGO:QUINENCO
|
CL |
|
Perusahaan Gas Negara Tbk PT
IDX:PGAS
|
ID |
Relative Value
The Relative Value of one Beijing Winsunny Pharmaceutical Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 21.82 CNY, Beijing Winsunny Pharmaceutical Co Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Beijing Winsunny Pharmaceutical Co Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Beijing Winsunny Pharmaceutical Co Ltd Competitors
Beijing Winsunny Pharmaceutical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
B
|
Beijing Winsunny Pharmaceutical Co Ltd
SSE:601089
|
4.1B CNY | 1.2 | 8.9 | 7.4 | 7.4 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
853.2B USD | 13.1 | 41.3 | 27.9 | 29.8 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.5B USD | 6 | 21.1 | 14.7 | 18.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF | 3.9 | 18.8 | 11.2 | 12.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
213.1B GBP | 4.9 | 28 | 15.6 | 22 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
288B USD | 4.4 | 15.8 | 9.8 | 11.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
222.8B CHF | 5.1 | 20.7 | 12.8 | 16.5 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.4 | 10.3 | 7.6 | 8.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.3B USD | 2.4 | 19.7 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.5B USD | 2.4 | 16.4 | 7 | 8.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
